Related references
Note: Only part of the references are listed.MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
Andres J. M. Ferreri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma
Aurelian Ungureanu et al.
JOURNAL OF NEUROLOGY (2021)
Clinical significance of interleukin-10 concentration in the cerebrospinal fluid of patients with primary central nervous system lymphoma
Mingying Geng et al.
ONCOLOGY LETTERS (2021)
High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma
Jie Shao et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis
V. Rimelen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas
Michalina Zajdel et al.
CANCERS (2019)
Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
Mathilde Postel et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid
Laura S. Hiemcke-Jiwa et al.
HEMATOLOGICAL ONCOLOGY (2018)
Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination
Myrto Costopoulos et al.
SEMINARS IN HEMATOLOGY (2018)
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities
Laura S. Hiemcke-Jiwa et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
Yangying Zhou et al.
NEOPLASIA (2018)
Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma
Keiichiro Hattori et al.
CANCER SCIENCE (2018)
MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma
Keiichiro Hattori et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Primary central nervous system lymphoma: essential points in diagnosis and management
Semra Paydas
MEDICAL ONCOLOGY (2017)
The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma
M. C. Mabray et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma
Alexander Baraniskin et al.
NEURO-ONCOLOGY (2016)
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
T. Nakamura et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
Genomic characterization of primary central nervous system lymphoma
Kazutaka Fukumura et al.
ACTA NEUROPATHOLOGICA (2016)
Accuracy of Flow Cytometry and Cytomorphology for the Diagnosis of Meningeal Involvement in Lymphoid Neoplasms: A Systematic Review
Simone Canovi et al.
DIAGNOSTIC CYTOPATHOLOGY (2016)
The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients
Ludovic Nguyen-Them et al.
EUROPEAN JOURNAL OF CANCER (2016)
The Challenge of Primary Central Nervous System Lymphoma
Julia Carnevale et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma
Yang Song et al.
SCIENTIFIC REPORTS (2016)
Liquid biopsies in patients with diffuse glioma
Myron G. Best et al.
ACTA NEUROPATHOLOGICA (2015)
High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates
Irina Bonzheim et al.
BLOOD (2015)
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski et al.
LANCET ONCOLOGY (2015)
miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth
Marija Mihailovich et al.
NATURE COMMUNICATIONS (2015)
Complications Following Stereotactic Needle Biopsy of Intracranial Tumors
Hani Malone et al.
WORLD NEUROSURGERY (2015)
Primary CNS lymphoma: in search of the evidence
Emili Montserrat
LANCET HAEMATOLOGY (2015)
Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system
Yasuo Sasagawa et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis
Dong Wei et al.
MOLECULAR NEUROBIOLOGY (2015)
Frameless image-guided stereotactic brain biopsies: emphasis on diagnostic yield
Sodaba Khatab et al.
ACTA NEUROCHIRURGICA (2014)
Serum MicroRNAs in HIV-Infected Individuals as Pre-Diagnosis Biomarkers for AIDS-NHL
Dharma R. Thapa et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma
Xuhua Mao et al.
NEUROLOGICAL SCIENCES (2014)
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
James L. Rubenstein et al.
BLOOD (2013)
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
Marzia Varettoni et al.
BLOOD (2013)
Primary CNS lymphoma
Andres J. M. Ferreri et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2012)
Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma
Alexander Baraniskin et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)
Takashi Sasayama et al.
NEURO-ONCOLOGY (2012)
Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
I. S. Haldorsen et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BLOOD (2011)
Steroids in neurooncology: actions, indications, side-effects
Patrick Roth et al.
CURRENT OPINION IN NEUROLOGY (2010)
Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology
Roland Schroers et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas
Roland Schroers et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
S. Hohaus et al.
ANNALS OF ONCOLOGY (2009)
Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas
Ping Mu et al.
GENES & DEVELOPMENT (2009)
Review: Primary CNS lymphoma
Uwe Schlegel
Therapeutic Advances in Neurological Disorders (2009)
Interleukin-10: new perspectives on an old cytokine
David M. Mosser et al.
IMMUNOLOGICAL REVIEWS (2008)
Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis -: a pilot study
B. Hildebrandt et al.
BMC CANCER (2007)
CSF analysis of IgH gene rearrangement in CNS lymphoma: Relationship to the disease course
Dana Ekstein et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity
KM Ansel et al.
IMMUNITY (2002)
Share Paper
